Pharmaceutical company Mylan N.V. (MYL), announcing what will be its final earnings update, reported Friday a profit for the third quarter that edged down 2 percent from last year, primarily due to higher income tax provisions. Total revenues for the…
Read MoreGilead In Deal With 5 Cos. To Make And Sell Remdesivir In 127 Countries
Gilead Sciences Inc. said it has signed non-exclusive voluntary licensing agreements with five generic drug makers to manufacture remdesivir, its experimental COVID-19 drug, for distribution in 127 countries. Foster City, California-based Gilead signed the licensing deals with five generic drug…
Read More